PriceSensitive

Empower Clinics (CSE:CBDT) exceeds 3000 tests in first month of operation

Health Care, Sponsored, The Watchlist
CSE:CBDT
02 June 2022 13:00 (EDT)

This browser does not support the video element.

Empower Clinics (CBDT) has confirmed more than 3000 Covid 19 tests and 750 pending appointments in and around the Port of Vancouver and Canada Place.

All of Empower’s COVID-19 testing solutions are fully accredited by the College of Physicians and Surgeons of British Columbia’s Diagnostic Accreditation Program (DAP)

Steven McAuley, Chairman and CEO of Empower Clinics, sat down with Coreena Robertson to highlight the updates.

“Serving well over 3000 clients is an important milestone for our accredited testing solutions in Vancouver providing significant new cash flow for the company and supporting our investment thesis for this project. It reasserts the importance and investment that we’ve made to be a fully accredited operation as per local B.C. regulation. It also allows our entire team, clients and shareholders to find confidence in the stability, quality and potential reach of our services while we are still early in the cruise season and peak tourist season for Vancouver – with countless conferences, tour groups and events -just ahead of us.”

With several ships carrying more than 4000 people, the Vancouver Fraser Port Authority expects more than 300 cruise ship calls for the 2022 season – a nearly 8 per cent increase from 2019.

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Empower is aggressively growing its clinical and digital presence across North America.

Empower Clinics Inc. (CBDT) is currently trading at C$0.09 per share.

 

Related News